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Abstract
Background
Frailty is common in older patients affected by chronic kidney disease (CKD). Since gut
microbiota (gMB) may contribute to frailty, we explored possible associations between gMB
and frailty in CKD.
Methods
We studied 64 CKD patients (stage 3b-4), categorized as frail (F, 38) and not frail (NF, 26)
according to Fried criteria, and 15 controls (C), all older than 65 years. In CKD we assessed
serum C-reactive protein, blood neutrophil/lymphocyte ratio, Malnutrition-inflammation
Score (MIS); gMB was studied by denaturing gel gradient electrophoresis (DGGE), high-
throughput sequencing (16S r-RNA gene), and quantitative real-time PCR (RT-PCR).
Results
No differences in alpha diversity between CKD and C and between F and NF patients
emerged, but high-throughput sequencing showed significantly higher abundance of poten-
tially noxious bacteria (Citrobacter, Coprobacillus, etc) and lower abundance of saccharoly-
tic and butyrate-producing bacteria (Prevotella spp., Faecalibacterium prausnitzii,
Roseburia spp.), in CKD respect to C. Mogibacteriaceae family and Oscillospira genus
abundance was positively related to inflammatory indices in the whole CKD cohort, while
that of Akkermansia, Ruminococcus and Eubacterium genera was negatively related. Com-
pared with NF, in F there was a higher abundance of some bacteria (Mogibacteriacee, Cor-
iobacteriacee, Eggerthella, etc), many of which have been described as more abundant in
other diseases.
Conclusions
These results suggest that inflammation and frailty could be associated to gMB modifica-
tions in CKD.
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Introduction
Frailty is highly frequent in patients affected by chronic kidney disease (CKD) (14–68%), its
prevalence increases with age and progression of kidney disease, and it has been associated
with worse quality of life and poor outcomes [1]. The ERA-EDTA guidelines suggest to evalu-
ate the presence of frailty in older patients with advanced CKD in order to better stratify their
overall risk and to program targeted rehabilitative interventions [2]. Growing evidence accu-
mulated in the last decade suggests that gut microbiota (gMB) composition may play a causal
role in determining the inflammatory and oxidative stress status in many clinical settings [3,4].
gMB changes have been described both in frail subjects and in CKD patients, with potential
worsening of their clinical outcomes [5,6].
As a matter of fact, gut dysbiosis has been reported in frail patients, and it is characterized
by a significant reduction in the number of Lactobacillus, Faecalibacterium prausnitzii and
Bacteroides-Prevotella groups, with a concomitant increase of Enterobacteriaceae [6]. Changes
of gMB composition, with increased Enterobacteria and reduced Lactobacillaceae and Prevo-
tellaceae, have been reported also in CKD, but only in few studies mainly focused on end stage
renal disease (ESRD) [7,8]. The coexistence of CKD-specific pathological conditions (dietary
restrictions, drugs, sedentary lifestyle, low fluid intake, slowed intestinal transit time, comor-
bidities), can enhance the potential proinflammatory effects of gMB changes, leading to
increased risk of inflammation, malnutrition and, eventually, global frailty [9–11].
Furthermore, aging is associated with increased chronic inflammation related to sarcope-
nia. Sarcopenia is also typical of CKD patients, as a consequence of reduced physical activity
and increased adiposity, and it induces low-grade chronic inflammation, the so called Inflam-
maging. Inflammaging is emerging as a central pathologic mechanism of aging, which predis-
poses to frailty and age-associated chronic diseases [12].
The prevalence of elderly and frail CKD patients is progressively increasing. Examining the
relationship between CKD and gMB in these patients, might give new insights for improving
clinical management of this high-risk cohort. Most of the few studies previously published on
this topic were carried out only in dialysis patients.
Therefore, the aim of this study is to explore the prevalence of frailty in a cohort of older
pre-dialysis CKD patients, in relation to gMB composition, and to examine possible gMB dif-
ferences between frail and not frail CKD patients.
Methods
Study design
In this observational study we evaluated cross sectionally 64 CKD patients (eGFR<45 ml/min/
1.73m2 not on dialysis), aged� 65 years, enrolled from a cohort of 101 prevalent CKD patients
in continuous follow-up at the outpatient clinic of the Department of Nephrology of Policli-
nico Ospedale Maggiore of Milan.
The study protocol was reviewed and approved by Ethics Committee of Comitato Etico
Milano Area 2; a written informed consent was signed by all participants. Partecipants were
recruited from 1st September 2015 to 6th December 2016. All eligible patients that fulfilled the
inclusion criteria were screened during the observational period and were asked to participate
to the study. 37 patients were excluded according to the exclusion criteria.
Exclusion criteria were inflammatory and/or autoimmune diseases and/or ongoing immu-
nosuppressive treatment for these pathologies (i.e. calcineurin inhibitors, steroids, methotrex-
ate, mycophenolic acid), cancer, use of probiotics/antibiotics within 3 months before study
entry, and inability to collaborate.
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CKD patients were compared with 15 healthy controls (C) with normal renal function
(eGFR>60ml/min/1.73m2) that were recruited among the relatives and friends of the
researchers involved in the project. Control subjects were matched for age and had to fulfill all
the selection criteria that were applied to CKD patients except of renal impairment. All eligible
CKD patients were classified into frail (F-CKD) and not frail (NF-CKD) according to Fried’s
Frailty Phenotype (FFP) score. Frail patients had to fulfil 3 of the following 5 criteria: a) weight
loss, b) walking slowness, c) exhaustion, d) weakness, e) low physical activity[13]. eGFR was
calculated from standard creatinine (determined by colorimetric method) using the CKD-EPI
equation [14].
Nutritional assessment was evaluated through: serum albumin, serum transferrin, body
mass index (BMI), and the Malnutrition Inflammation Score (MIS) questionnaire, which con-
sists of ten components, each of them envisaging 4 levels of severity, from 0 (normal) to 3
(severely malnourished), with a total score ranging from 0 to 30 [15]. The evaluation of body
composition was assessed by multiphase Bioelectrical Impedance Analysis, BIA (Body Compo-
sition Monitor, Fresenius Medical Care, Bad Homburg, Germany). We evaluated also some
inflammatory indices, such as serum C-reactive protein (CRP, dosed by turbidimetric method)
and blood neutrophil to lymphocyte (N/L) ratio, that were correlated with gMB composition.
Nutritional and inflammatory parameters have been assessed only in CKD population.
Individuals were requested to complete a questionnaire regarding antibiotics, probiotics
and/or any immunosuppressive drugs used within the month before fecal sample collection.
Furthermore, all subjects were asked to fill a diary regarding dietary intake in the two days
before the stool collection (these data were subsequently elaborated with Winfood software,
Medimatica Surl). Feces were collected by each volunteer at home on the day preceding the
visit, using 20 ml plastic sterile stool collection containers and placed in their own freezer at
-18/-20˚C overnight, before being stored at -80˚C in our laboratories until analysis.
DNA extraction and PCR-DGGE
Bacterial DNAs were extracted from 50 mg of fecal sample using the FastDNA™ SPIN Kit for
Soil (MP Biomedicals, Switzerland) following the manufacturer’s instructions. DNA was
eluted with 100 μl of elution buffer and stored at −20˚C until further analysis. Then extracted
DNAs were used as target in PCR reactions with universal primers (Hda1GC-Hda2) targeting
the 16SrRNA gene [16]. The amplification conditions, gel composition and run have been
already described by Miragoli et al. 2016 [17]. Gel were analyzed with Fingerprinting II SW
software (Bio-Rad Laboratories, Hercules, CA, USA) using Pearson’s coefficient, using the
Unweighted Pair Group Method with Arithmetic Mean algorithm (UPGMA). The Shannon
Wiener Diversity (H) Index of the biodiversity was calculated using the previously reported
formula.[18]
As DGGE can only provide a qualitative estimate of the levels of a specific bacterial group,
we subsequently performed Illumina sequencing of V3-V4 regions of 16S rRNA gene.
High-throughput sequencing and bioinformatic analysis
PCR amplifications were carried out using the primers 343F (5’TACGGRAGGCAGCAG 3’)
and 802R (5’TACNVGGGTWTCTAATCC 3’). A specific tag (7 nucleotides) was attached to
forward primer for demultiplex of sequences during bioinformatics analysis. The PCR amplifi-
cation was performed in triplicate using 1 ng of DNA for each reaction. The PCR protocol
included an initial denaturation (95˚C, 3 min), followed by 25 cycles of denaturation at 94˚C
for 30 sec, annealing at 52˚C for 30 sec and extension at 72˚C for 30 sec and elongation at
72˚C for 7 min. Each reaction was carried out in a 25 μl of mixture containing 1 μl of DNA,
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0.5 μM of each primer. To check eventual contaminations during PCR reaction assembly, each
reaction mixture was prepared in duplicate. One reaction was prepared as already mentioned
the other one represented the negative control to which 1 μl of water was added. The PCR
products were checked by agarose gel electrophoresis and then quantified using the Qubit HS
dsDNA fluorescence assay (Life Technologies, Carlsbad, CA, USA). Amplicons were polled in
equimolar concentration (20 ng each) and then purified by the Agencourt AMPure XP PCR1
Purification system (Beckman Coulter, Brea, CA, USA).
Sequencing was performed using Illumina’s MiSeq platform (Parco Tecnologico Padano,
Lodi, Italy) with 300 bp paired-end mode and v3 chemistry. After demultiplexing and quality
check the reads were trimmed using Qiime 1.9. This allows the reads to be truncated after base
quality dropping below 15 (Phred-scale) and reads ID to be compatible for the following
QIIME pipeline scripts. We used the 97% clustered Qiime formatted Greengenes v.13.8 refer-
ence database. Alpha diversity index metrics (observed OTUs, Chao1, Observed species, Shan-
non, Simpson and Goods coverage) were calculated using Qiime pipeline. PCA was performed
on OTUs using post hoc test Tukey-Kramer by Stamp software. The linear discriminant analy-
sis (LDA) with effect size measurements (LEfSe) was used to identify indicator bacterial groups
within the microbial communities.
Real time PCR (RT-PCR)
To confirm statistical analysis RT-PCR reactions were performed to quantify representative group
of bacteria resulted statistically significant. The RT-PCR reactions were performed for Eggerthella
lenta, Lactobacillus spp. F. prausnitzii, and Citrobacter spp. as already described by Cho et al [19],
Byun et al [20], Sokol et al [21] and Patel et al [22], respectively. Moreover, Roseburia spp. and Pre-
votella-Bacteroides group quantification was performed as described by Larsen et al [23]. Standard
curves were prepared by decimal dilution of reference DNAs. The RT-PCR reactions were per-
formed in a LightCycler1 480 Instrument II (Roche Life Science, Mannheim, Germany) and
amplification conditions were set up in order to achieve optimal reaction efficiency. Results were
expressed as percentage of ng of specific target gene/ ng of total DNA.
Statistical analysis
Values for results were expressed as means ± SD or medians ±IQR. Continuous variables were
compared using the unpaired t-test and categorical variables were compared using the Chi-
squared analysis. When data were non-normally distributed, two-tailed nonparametric Mann-
Whitney test was used instead. Canonical correspondence analysis (CCA) was performed using
Pearson correlation coefficient to test the association between discriminant group of bacteria and
clinical parameters across the three groups of individuals using the R package microbiome. The
Benjamini and Hochberg’s FDR-controlling procedure was used for multiple comparisons.
Statistical significance was determined using two-tailed Student’s t test to compare samples
and one or two-way ANOVA to compare samples from different groups of individuals. Graph-
Pad Prism 6 software was used to analyze and plot the data. P< 0.05 was considered statisti-
cally significant.
Results
Patients and controls
Clinical characteristics of CKD and C cohorts are shown in Table 1. In addition to the expected
differences in renal function parameters, age and BMI were significantly higher in CKD
patients, with a greater prevalence of female gender and diabetes compared to C.
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38 (59%) of CKD patients were categorized as frail according to the FFP scale criteria, while
the remaining 26 (41%) were not frail (Table 2). Twenty-four (63%) F-CKD patients were
affected by diabetes, compared to 13 (50%) in NF-CKD group, but this difference was not sta-
tistically significant. No significant differences between F- and NF-CKD groups were found in
any of the explored variables, except for MIS, which was higher in F-CKD compared to
NF-CKD (Table 2).
PCR-DGGE analyses
A preliminary investigation was conducted on fecal samples by mean of PCR-DGGE analysis.
Software analysis of the PCR-DGGE profiles (Fig 1) provided a dendrogram in which the pat-
tern of bands were grouped on the basis of their similarity level that graphically was indicated
by the similarity coefficient; the height of the columns was inversely proportional to the simi-
larity between the bands. The software grouped all the analyzed profiles in four clusters.
F-CKD and NF-CKD patients were equally distributed in the four clusters, whereas C were
grouped mainly in the first and last clusters. The first cluster grouped six out of 15 C subjects
and two out of 29 NF-CKD profiles with a degree of similarity lower (from 45 to 75%) than
those of the other three clusters. However, the average number of bands visible in the
Table 1. Clinical parameters among CKD patients and controls.
Characteristics CKD (n = 64) Controls (n = 15) p value
Age (years) 80.7±6.2 73.7±7.6 0.0003 �
males/females 43 /21 4/11 0.007 �
eGFR (ml/min/1,73 m2) 26±11 75±11 <0.0001 �
Diabetics(n) 37 4 0.043 �
BMI (kg/m2) 28.4±4.7 25.5±2.9 0.0301 �
CKD, Chronic kidney disease; eGFR, estimated glomerular filtration rate; BMI, Body mass index
https://doi.org/10.1371/journal.pone.0228530.t001
Table 2. Clinical parameters among F-CKD and NF-CKD patients.
Characteristics Frail (38) Not Frail (26) p value
Age (years) 81,8±5,8 79,03±6,6 0.079
Sex, male (female) 22 (16) 21 (5) 0.55
sCreatinine 2.36 2.65 0.24
GFR (CKD-EPI) 25,68±9,7 26,2±13,3 0.79
CKD IIIb patients 12 9 0.79
CKD IV patients 26 17 0.79
Diabetes 24 13 0.29
BMI 28,77±5,4 27,7±3,4 0.38
LTM (lean tissue mass) % 45,7±12,4 52,2±8,7 0.05
CRP 0,37±0,6 0,26±0,24 0.4
MIS 7,6±5,4 3,96±1,9 0.0017 �
Pre-albumin 27,3±4,4 29,4±6,2 0.11
Hypertension 35 23 0.623
CV events 22 15 0.868
N/L 2,53±1 2,51±1 0.94
eGFR, estimated glomerular filtration rate; CRP, C-reactive protein; BMI, Body mass index; LTM, lean tissue mass;
MIS, malnutrition inflammation score, N/L neutrophil/lymphocytes ratio
https://doi.org/10.1371/journal.pone.0228530.t002
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PCR-DGGE profiles of each group of subjects (CKD 25.2± 4.8; C 26.46 ± 2.47, F-CKD
25.26 ± 4.19; NF-CKD 25.15 ± 5.7; mean ± sd) was very similar with no statistically significant
difference in biodiversity being observed.
High-throughput sequencing in CKD compared to C
The PCR-DGGE analysis is a rapid method to detect differences in dominant microbiota com-
position between samples. It is a qualitative analysis based on profile comparison of amplicons
obtained by amplification of 16SrRNA gene. This technique has some limitations, and in par-
ticular, allows the detection of dominant bacteria present in analyzed samples while those pres-
ent in lower abundance are neglected. In order to deeply investigate the gut microbiota
composition of CKD and C patients we decide to use a metabarcoding approach.
Illumina sequencing was performed on V3-V4 regions of 16S rRNA gene and OTU
obtained by bioinformatics analysis were investigate by mean of alpha and beta diversity.
Alpha diversity analysis revealed no significant differences in either OTU richness (Chao1
index) or OTU diversity (Simpson, Shannon index) between the three groups (F-CKD,
NF-CKD and C) (Fig 2B). To find differences in fecal bacterial communities between the three
groups of individuals, a principal component analysis (PCA) was performed on OTUs. PCA
Fig 1. Dendrogram constructed from analysis of PCR-DGGE gels using Pearson’s correlation coefficient and the
unweighted-pair group method. F-CKD (blue squares); NF-CKD (red squares); C (yellow squares).
https://doi.org/10.1371/journal.pone.0228530.g001
Fig 2. A. Graphical PCA of CKD-F (orange squares), CKD-NF (green triangles) and C (blue balls) microbial communities. The analysis was carried out at OTU level.
B. Graphic summary of alpha-diversity indices. Comparison of Chao1, Shannon, and Simpson indices of gut microbiota between CKD-F, NF and Controls.
https://doi.org/10.1371/journal.pone.0228530.g002
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ordination plot did not revealed distinct clusters, suggesting that no significant differences in
microbial composition were found between F-CKD, NF-CKD and C. (Fig 2A).
We also compared gMB composition of CKD- diabetic and non-diabetic patients using
PCA analysis and Anova test in order to detect differential groups of bacteria. No statistically
significant differences between the analyzed groups (CKD-D, CKD-ND and C) were found.
In order to evaluate which group of bacteria were enriched in the different groups accord-
ing to metabarcoding data, linear discriminant analysis (LDA) coupled with effect size mea-
surements (LEfSe) was applied. Lefse analysis identified Citrobacter spp. and Roseburia spp.,
respectively, as the most differentially abundant genera in CKD and C (Fig 3). Lower abun-
dance of Roseburia spp. in CKD respect to C was confirmed also by RT-PCR (Fig 5D); unfor-
tunately, no specific couple of primers was available for RT-PCR quantification of Citrobacter
spp. No significant differences were found between the two groups at the family level (S1 Fig).
The relative abundance of genus showed statistically significant differences between CKD and
C (Fig 4A and 4B). Namely, a higher relative abundance of genera Lactobacillus, Coprobacillus,
Anaerotruncus and Citrobacter and Ruminococcus torques species (S2 Fig) was observed.
Moreover, a reduction of Prevotella spp., F. prausnitzii and Roseburia spp. (all saccharolytic
and butyrate producing bacteria) were observed in CKD patients respect to controls.
RT-PCR analysis confirmed significant lower abundance of F. prausnitzii and Roseburia
spp (p = 0.0011 and p = 0.00128 respectively, see Fig 5A and 5D) and higher Lactobacillus spp
counts (p = 0.0053) in CKD patients compared to C (Fig 5B). No significant difference in Pre-
votella spp. content was observed in CKD and C groups (p = 0.185) (Fig 5C).
High-throughput sequencing in F versus NF CKD patients
A statistically significant increase in the relative abundance of genera Lactobacillus and Oscil-
lospira and Coriobacteriacee family in stools of F-CKD as compared to NF-CKD patients was
observed (Fig 4C). However, the quantification of Lactobacillus spp. by RT-PCR did not con-
firm the significant differences between F and NF observed in the sequences analyses
(p = 0.1958).
Fig 3. Graphical results obtained with logarithmic linear discriminant analysis (LDA) score higher than 2 determined by effect size (LefSe). Indicator bacterial
groups within the CKD and Control groups were: Citrobacter genus resulted to be more abundant in CKD patients than in C whereas Roseburia spp. was higher in C
than in CKD group.
https://doi.org/10.1371/journal.pone.0228530.g003
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Furthermore, we observed a statistically significant increased abundance of Eggerthella
(particularly E. lenta species, S2 Fig), Erwinia, Anaerotruncus, Coprobacillus genera and Mogi-
bacteriacee family (Fig 4D). Moreover, an increase of OTU related to Eubacterium dolichum,
Eubacterium cylindroides and Dorea spp in the frail group was observed (S2 Fig).
Correlation analysis of clinical/ inflammatory indices and gMB
In CKD cohort, a positive correlation between unclassified Mogibacteriaceae and Oscillospira
abundance with CRP and MIS levels, respectively was found, whereas Akkermansia, Rumino-
coccus and Eubacterium genera were negatively correlated to N/L ratio (Table 3).
Discussion
Various modifications of gMB composition have been described in CKD patients. The rela-
tionship between CKD and gMB is probably bidirectional, since kidney diseases may disrupt a
balanced gMB and in turn alterations in gMB could affect kidney disease progression and the
degree of the associated comorbidities (e.g. CV complications).
Fig 4. Statistically significant bacterial groups expressed as relative abundance (%). �p< 0.05, ��p< 0.01. (A, B): Green and yellow bars represent CKD
patients and healthy controls respectively. On the left, there are the bacterial genera with higher relative abundance (A), on the right those with lower relative
abundance (B). (C, D): Blue and red bars represent Frail (F) and Not frail (N) patients respectively; bacterial genera with higher relative abundance (C),
bacterial genera with lower relative abundance (D).
https://doi.org/10.1371/journal.pone.0228530.g004
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It is also acknowledged that frailty is very common in CKD patients, particularly in elderly
subjects, with high impact on their quality of life and clinical outcomes. Frailty is also associ-
ated per se with changes in gMB composition [24,25].
In our study, the prevalence of frailty in the CKD cohort was 59%, which was consistent
with data previously published [1,26]. F-CKD patients had higher MIS compared with
NF-CKD, suggesting that frailty is associated with higher degree of inflammation and malnu-
trition. The main aim of this study was to evaluate whether there were differences in gMB
composition between F and NF-CKD individuals. However, our results cannot clarify whether
a direct cause-effect relationship does exist between gMB changes and frailty in CKD patients
or both these findings are merely associated through other common causal factor(s) (e.g.
inflammation).
Our results obtained with the PCR-DGGE method show that gMB profiles of C group clus-
ter into two main groups, one of which was characterized by a trend toward a greater inter-
individual variability, compared to CKD patients. The only published study which assessed
gMB through PCR-DGGE method in 20 CKD non-dialysis patients, did not demonstrate any
difference compared with 19 controls [27]. On the other hand, we did not find any significant
difference in the richness of bands between the gMB profiles of CKD (F and NF) and controls.
However, the Illumina technique, though confirming no significant differences in α diver-
sity of the compared groups, found some distinctive features in gMB composition in CKD
compared with C and in F-CKD compared with NF-CKD. In particular, CKD patients showed
Fig 5. Representation of RT-PCR quantification (expressed as log of relative abundance) of species resulted to be statistically different by
sequence analysis.
https://doi.org/10.1371/journal.pone.0228530.g005
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a significantly increased abundance of bacteria (Citrobacter, Anaerotruncus, Coprobacillus gen-
era and Ruminococcus torques species) which have been recently associated with other patho-
logical conditions, such as IBD and vascular and inflammatory diseases [4, 17, 28–30].
Citrobacter and Ruminococcus torques are bacteria particularly prone to generate phenolic
compounds, including p-cresyl sulphate (PCS) which accumulates in CKD patients, and has
been suggested to play a causal role in cardiovascular complications [31,32]. Furthermore,
Citrobacter species are also involved in the production of another uremic toxin, indoxyl-sul-
fate, through the conversion of tryptophan to indole. Citrobacter genus belongs to Enterobac-
teriaceae family, urease-producing bacteria whose abundance has been reported to be
increased in CKD by other Authors [6,25,26]. However, we did not find any difference in the
relative abundance of the other species belonging to the Enterobacteriaceae family between
CKD patients and controls. This partial discrepancy could be explained by the fact that previ-
ously published studies analyzed gMB composition in ESRD patients (often undergoing dialy-
sis treatment), whereas our cohort was composed of individuals affected by CKD 3b-4, which
is characterized by a less severe degree of inflammation.
Consistently with existing literature, we found a reduced abundance of saccharolytic and
butyrate- producing bacteria (Prevotella, F. prausnitzii, Roseburia) in CKD patients respect to
controls. Butyrate seems to play an important role in the maintenance of gut barrier function:
it promotes colon motility; reduces inflammation; increases visceral vascularization; inhibits
tumor cell progression; induces differentiation of T-regulatory cells, etc. [33]
It is widely agreed that lactobacilli play a beneficial role in the intestinal tract. As a matter of
fact, in the few data derived from animal studies and small CKD cohorts, a decreased abun-
dance of lactobacilli was associated with reduced renal function [8, 11, 34]. Unlike previous
studies, we found that the abundance of Lactobacillus genus was even higher in CKD patients
compared with controls. A non-statistically significant trend towards higher lactobacilli counts
in both hemodialysis and CKD patients, compared with healthy controls, was also reported in
a previous study, which applied culture methodology [35]. We observed that Lactobacillus,
Coprobacillus and Anaerotruncus genera have a higher abundance not only in CKD patients
respect to controls, but also in F respect to NF patients. Though the two latter bacteria have
been already associated with a worse state of health, there is not a counterintuitive explanation
for the finding of increased Lactobacillus genus abundance in F-CKD patients, given that this
bacterium is commonly considered as a beneficial one.
In an attempt to reconcile these discordant data, we should consider that observations from
Vaziri et al [8] were based on experimental studies in rats, which are not completely compara-
ble with the results obtained in humans. On the other hand, Wang et al study [11] was per-
formed in a small cohort of peritoneal dialysis patients, showing a reduced abundance of only
two lactobacilli species (Lactobacillus plantarum and Lactobacillus paracasei).
Table 3. Correlation analysis of CRP, MIS and N/L values and gMB.
Eubacterium spp. Ruminococcus spp. Akkermansia spp. Unclass.Mogibacteriaceae Family Oscillospira spp.
CRP p 0.64 0.38 0.73 0.029 0.53
R -0.06 -0.11 -0.0447 0.2738 -0.0802
MIS p 0.47 0.94 0.97 0.27 0.044
R 0.09 -0.01 0.004 0.14 0.25
N/L p 0.025 0.013 0.0048 0.052 0.39
R -0.28 -0.3 -0.34 -0.24 -0.11
C-reactive protein; MIS malnutrition inflammation score, N/L neutrophils/lymphocytes ratio. r: correlation coefficient. �p < 0.05.
https://doi.org/10.1371/journal.pone.0228530.t003
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Moreover, it should be considered that also lactobacilli, as some other genera (Clostridium,
Bacteroides, Enterobacter, Bifidobacterium), can metabolize aromatic amino acids to phenolic
compounds (including PCS) which accumulate in CKD, since their clearance is mainly renal
[36]. Therefore, some lactobacilli species might contribute to the production of toxic com-
pounds, although few interventional studies showed that their administration as probiotics
was followed by a reduction of PCS levels [37]. Alternatively, the increase in lactobacilli could
simply be due to the reduction of competitive species and therefore being the consequence of
an altered balance of the microbial environment, as described in other chronic diseases [38].
It is noteworthy that although no apparent differences in macronutrients and fiber intake
were found between F-CKD, NF-CKD and Controls through dietary diary analyses, 24
patients in the CKD cohort (13 F-CKD and 11 NF-CKD) were prescribed aproteic food, that
may have influenced this finding since it is enriched with fibers and inulin, potentially acting
as prebiotics and supporting the growth of lactobacilli [39,40].
Regarding associations of gMB composition with clinical parameters and inflammatory
indices, we found that a greater mean abundance of unclassified Mogibacteriaceae and Oscil-
lospira genus was positively correlated with CRP and MIS levels, respectively, and that Akker-
mansia, Ruminococcus and Eubacterium genera, traditionally considered to be associated with
a healthy gMB, were negatively related to N/L ratio.
Regarding the associations between gMB composition and frailty, we found a significant
increase in the abundance of several bacterial species in F-CKD respect to NF-CKD. Many of
these bacteria (Coriobacteriaceae family, Anaerotruncus, Coprobacillus and Dorea genera and
Eubacterium dolichum and Eggerthella lenta species) have already been associated to frailty in
various studies [6, 24, 25, 41, 42]. Some of them (Eggerthella, Coprobacillus and Oscillospira
genera) have been previously described as correlates of biological aging or abundant in elderly
individuals (Mogibacteriacaee, Coriobacteriaceae families and Lactobacillus, Eubacterium cylin-
droides species) [43,44]. Furthermore, some bacteria seem to be positively correlated also with
different nutritional and physical features: Eubacterium dolichum has been associated with obe-
sity and western diet in mice, and Oscillospira genus has been found in high concentrations in
the stools of lean subjects [44,45]. The latter has been also associated with urinary PCS levels
and positively correlated with age in previous studies [28,44]. In our cohort, Oscillospira genus
significantly correlated with MIS, which is significantly higher in F-CKD individuals. Neverthe-
less, although F-CKD have lower lean mass compared with NF-CKD, this difference was not
statistically significant. These results might suggest that frailty could be in part dependent more
on functional than structural changes of muscular and/or neurological systems.
In conclusion, many alterations in gMB composition seem to be related to both CKD and
frail condition. If this might play a casual role in frailty through an unbalanced production of
toxic substance(s), or if gMB changes are merely a consequence of different dietary and life-
style behaviors of frail patients, it cannot be explained by the present study and all the yet avail-
able data. Further studies, possibly utilizing new high-throughput tools, will be required to
understand the potential correlations between gMB composition and other inflammation and
oxidative stress markers in these patients. If a cause-effect relationship between gMB alter-
ations and frailty in CKD will be demonstrated, the restoration of a healthy gMB, using pro- or
prebiotics or through the correction of lifestyle and dietary behaviors, could be a strategy for
reducing the comorbidity burden of CKD patients.
Our study has a design limitation regarding the small sample size of the control group that
prevented us from performing a case-control analysis. This could have biased gMB differences
that were found between CKD and healthy control groups. However, we believe that the major
finding of our study is the significant difference of gMB composition found between F-CKD
and NF-CKD patients.
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Supporting information
S1 Fig. Distribution of bacterial families, expressed as relative abundance, in samples of
control group (C), CKD frail (CKD-F) and not frail (CKD-NF) subjects.
(TIF)
S2 Fig. Bacterial species found to be statistically different between CKD- F, -NF and Con-
trols at high-throughput sequencing are expressed below as relative abundance normalized
with cumulative-sum scaling (CSS) at the ANOVA analysis. Blue, red and yellow bars repre-
sent Frail, Not frail and Controls respectively. �p< 0.05, ��p< 0.01.
(TIF)
S1 Table.
(XLS)
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